The End Of ‘Regulatory Science’ At US FDA – The Term, Not The Idea
Former Commissioner Margaret Hamburg made advancing regulatory science a centerpiece of her tenure, but it sounds like the term ‘regulatory science’ has outlived its usefulness.
You may also be interested in...
Meeting to address opioid abuse crisis was also a trial of whether FDA could conduct important public business using online-only technology.
The latest flurry of Executive Order activity on drug pricing reinforces the message that the President wants to own the headlines for being tough on the drug industry as Election Day looms. Looking for substance beyond that goal is a fool’s errand – but the headlines could still have significant consequences no matter who wins in November.